Enovix Corporation (NASDAQ:ENVX - Get Free Report) traded up 1.8% during trading on Thursday . The stock traded as high as $14.78 and last traded at $14.82. 2,586,775 shares traded hands during mid-day trading, a decline of 59% from the average session volume of 6,307,545 shares. The stock had previously closed at $14.56.
Analyst Upgrades and Downgrades
Several research analysts recently commented on the stock. JPMorgan Chase & Co. restated a "neutral" rating and issued a $12.00 price target (up previously from $9.00) on shares of Enovix in a report on Thursday. Benchmark raised their price target on shares of Enovix from $15.00 to $25.00 and gave the company a "buy" rating in a report on Friday. B. Riley restated a "buy" rating and issued a $17.00 price target (up previously from $12.00) on shares of Enovix in a report on Thursday, July 10th. Craig Hallum restated a "buy" rating and issued a $15.00 price target (up previously from $12.00) on shares of Enovix in a report on Tuesday, July 8th. Finally, TD Securities decreased their target price on shares of Enovix from $10.00 to $7.00 and set a "hold" rating for the company in a research note on Thursday, May 1st. Six investment analysts have rated the stock with a hold rating and seven have assigned a buy rating to the company. According to data from MarketBeat.com, Enovix has an average rating of "Moderate Buy" and a consensus target price of $18.73.
Read Our Latest Stock Report on Enovix
Enovix Stock Performance
The company has a quick ratio of 4.49, a current ratio of 4.68 and a debt-to-equity ratio of 0.71. The firm's fifty day moving average is $10.43 and its 200-day moving average is $9.27.
Enovix declared that its board has approved a share buyback plan on Wednesday, July 2nd that authorizes the company to buyback $60.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 3.1% of its stock through open market purchases. Stock buyback plans are often a sign that the company's board of directors believes its stock is undervalued.
Institutional Inflows and Outflows
A number of large investors have recently added to or reduced their stakes in the stock. Strong Tower Advisory Services boosted its stake in Enovix by 1.4% during the 2nd quarter. Strong Tower Advisory Services now owns 146,031 shares of the company's stock valued at $1,510,000 after acquiring an additional 1,986 shares during the last quarter. Blair William & Co. IL boosted its stake in Enovix by 3.3% during the 2nd quarter. Blair William & Co. IL now owns 318,998 shares of the company's stock valued at $3,298,000 after acquiring an additional 10,203 shares during the last quarter. Clear Creek Financial Management LLC boosted its stake in Enovix by 17.2% during the 2nd quarter. Clear Creek Financial Management LLC now owns 58,335 shares of the company's stock valued at $603,000 after acquiring an additional 8,570 shares during the last quarter. Fortis Advisors LLC raised its position in shares of Enovix by 16.4% during the 2nd quarter. Fortis Advisors LLC now owns 14,200 shares of the company's stock valued at $147,000 after acquiring an additional 2,000 shares in the last quarter. Finally, Wealthcare Advisory Partners LLC raised its position in shares of Enovix by 8.2% during the 2nd quarter. Wealthcare Advisory Partners LLC now owns 22,640 shares of the company's stock valued at $234,000 after acquiring an additional 1,714 shares in the last quarter. 50.92% of the stock is currently owned by institutional investors.
About Enovix
(
Get Free Report)
Enovix Corporation designs develops and manufactures silicon-anode lithium-ion batteries. It serves wearables and IoT, smartphone, laptops and tablets, industrial and medical, and electric vehicles industries. The company was founded in 2007 and is headquartered in Fremont, California.
Further Reading
Before you consider Enovix, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Enovix wasn't on the list.
While Enovix currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat's analysts have just released their top five short plays for August 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.